Health
MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines – News-Medical.Net
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells…
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted…
Continue Reading
-
General22 hours agoa pivotal moment in Liberal power struggle
-
Noosa News22 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General20 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter
-
General12 hours agoWork to do: net-zero jobs yet to resonate in classroom